Country: Malta
Lingwa: Ingliż
Sors: Medicines Authority
INSULIN RECOMBINANT, HUMAN
Eli Lilly & Co. Limited
A10AD01
INSULIN RECOMBINANT, HUMAN
SUSPENSION FOR INJECTION
INSULIN RECOMBINANT, HUMAN 100 IU/ml
POM
DRUGS USED IN DIABETES
Authorised
2005-09-26
PACKAGE LEAFLET: INFORMATION FOR THE USER HUMULIN M3 (MIXTURE 3) 100 IU/ML SUSPENSION FOR INJECTION IN CARTRIDGE (INSULIN, HUMAN) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your diabetes specialist nurse, doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your diabetes specialist nurse, doctor or pharmacist. IN THIS LEAFLET: 1. What Humulin M3 is and what it is used for 2. Before you use Humulin M3 3. How to use Humulin M3 4. Possible side effects 5. How to store Humulin M3 6. Further information 1. WHAT HUMULIN M3 IS AND WHAT IT IS USED FOR Humulin M3 contains the active substance human insulin, which is used to treat diabetes. You get diabetes if your pancreas does not make enough insulin to control the level of glucose in your blood (blood sugar). Humulin M3 is used to control glucose in the long term. It is a premixed suspension of rapid and long acting insulin. Its action is prolonged by the inclusion of protamine sulfate in the suspension. Your doctor may tell you to use Humulin M3 as well as a longer-acting insulin. Each kind of insulin comes with its own patient information leaflet to tell you about it. Do not change your insulin unless your doctor tells you to. Be very careful if you do change insulin. Each type of insulin has a different colour and symbol on the pack and the cartridge so that you can easily tell the difference. 2. BEFORE YOU USE HUMULIN M3 DO NOT USE HUMULIN M3 IF YOU: - THINK Aqra d-dokument sħiħ
HUMULIN M3 CARTRIDGE SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Humulin M3 (Mixture 3) 100 IU/ml suspension for injection in cartridge 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 100 IU human insulin (produced in _E. coli_ by recombinant DNA technology). One cartridge contains 3 ml equivalent to 300 IU of biphasic isophane insulin – 30 % soluble insulin / 70 % isophane insulin. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM A suspension for injection in a cartridge. Humulin M3 is a sterile suspension of human insulin in the proportion of 30 % soluble insulin to 70 % isophane insulin. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The dosage should be determined by the physician, according to the requirement of the patient. Humulin M3 should be given by subcutaneous injection but may although not recommended, also be given by intramuscular injection. This formulation should not be administered intravenously. Subcutaneous administration should be in the upper arms, thighs, buttocks or abdomen. Use of injection sites should be rotated so that the same site is not used more than approximately once a month. Care should be taken when injecting any Humulin insulin preparations to ensure that a blood vessel has not been entered. After any insulin Aqra d-dokument sħiħ